The stock price of Bone Biologics Corp (NASDAQ: BBLG) has dropped by -8.92 compared to previous close of 0.99. Despite this, the company has seen a fall of -9.53% in its stock price over the last five trading days. businesswire.com reported 2024-08-02 that BURLINGTON, Mass.–(BUSINESS WIRE)–Bone Biologics Corporation (“Bone Biologics” or the “Company”) (Nasdaq: BBLG, BBLGW), a developer of orthobiologic products for spine fusion markets, today announced that it has entered into a definitive agreement for the exercise of certain existing warrants to purchase an aggregate of 781,251 shares of its common stock having an exercise price of $2.43 per share, originally issued in March 2024. The issuance of the shares of common stock issuable upon exerc.
Is It Worth Investing in Bone Biologics Corp (NASDAQ: BBLG) Right Now?
There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for BBLG is 0.53M and currently, short sellers hold a 9.47% ratio of that float. The average trading volume of BBLG on December 26, 2024 was 274.69K shares.
BBLG’s Market Performance
The stock of Bone Biologics Corp (BBLG) has seen a -9.53% decrease in the past week, with a -24.01% drop in the past month, and a -59.06% fall in the past quarter. The volatility ratio for the week is 9.62%, and the volatility levels for the past 30 days are at 10.31% for BBLG. The simple moving average for the past 20 days is -21.62% for BBLG’s stock, with a -43.46% simple moving average for the past 200 days.
BBLG Trading at -32.43% from the 50-Day Moving Average
After a stumble in the market that brought BBLG to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -91.48% of loss for the given period.
Volatility was left at 10.31%, however, over the last 30 days, the volatility rate increased by 9.62%, as shares sank -31.29% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -43.39% lower at present.
During the last 5 trading sessions, BBLG fell by -14.28%, which changed the moving average for the period of 200-days by -64.84% in comparison to the 20-day moving average, which settled at $1.1459. In addition, Bone Biologics Corp saw -78.98% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for BBLG
The total capital return value is set at -1.01. Equity return is now at value -109.17, with -91.58 for asset returns.
Currently, EBITDA for the company is 0.48 million with net debt to EBITDA at 2.03. The liquidity ratio also appears to be rather interesting for investors as it stands at 14.87.
Conclusion
In conclusion, Bone Biologics Corp (BBLG) has seen bad performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
